Bristol-Myers Squibb
BMY
#189
Rank
A$159.94 B
Marketcap
A$78.57
Share price
0.38%
Change (1 day)
-11.32%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2025 (TTM): A$74.92 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is A$72.36 Billion. In 2024 the company made a revenue of A$77.65 Billion an increase over the revenue in the year 2023 that were of A$66.05 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$74.92 B-3.51%
2024 A$77.65 B17.55%
2023 A$66.05 B-2.61%
2022 A$67.83 B6.02%
2021 A$63.98 B15.71%
2020 A$55.29 B48.08%
2019 A$37.34 B16.6%
2018 A$32.02 B20.34%
2017 A$26.61 B-1.26%
2016 A$26.95 B18.56%
2015 A$22.73 B17.16%
2014 A$19.40 B5.63%
2013 A$18.36 B8.33%
2012 A$16.95 B-18.16%
2011 A$20.71 B8.02%
2010 A$19.18 B3.2%
2009 A$18.58 B-36.33%
2008 A$29.19 B39.6%
2007 A$20.91 B-7.98%
2006 A$22.72 B-13.43%
2005 A$26.24 B15.65%
2004 A$22.69 B-19.75%
2003 A$28.28 B-12.05%
2002 A$32.16 B-14.43%
2001 A$37.58 B10.17%
2000 A$34.11 B15.71%
1999 A$29.48 B-1.28%
1998 A$29.86 B16.49%
1997 A$25.63 B35.18%
1996 A$18.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
A$94.59 B 30.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$96.77 B 33.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$89.52 B 23.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$84.93 B 17.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$71.60 B-1.06%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
A$87.57 B 21.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$138.83 B 91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$89.85 B 24.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$54.19 B-25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$15.16 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA